As per MRFR analysis, the US Ureteral Stents Market Size was estimated at 122.82 (USD Million) in 2023. The US Ureteral Stents Market Industry is expected to grow from 130(USD Million) in 2024 to 240 (USD Million) by 2035. The US Ureteral Stents Market CAGR (growth rate) is expected to be around 5.732% during the forecast period (2025 - 2035).
The US Ureteral Stents Market is experiencing significant trends driven by advancements in medical technology and increasing awareness of urinary tract disorders. One of the key market drivers is the rising prevalence of kidney stones and urinary tract infections, which stimulate the demand for ureteral stenting procedures. Improved healthcare infrastructure and technological innovations in stent design, such as biocompatible materials and drug-eluting stents, enhance patient outcomes and safety, thus driving market growth.
Opportunities in this market are primarily rooted in the increasing adoption of minimally invasive surgical techniques. As healthcare providers seek to improve patient recovery times and reduce complications associated with traditional surgery, ureteral stents have gained acceptance. Additionally, the development of next-generation stents that offer better comfort and reduced chances of encrustation is an avenue that can be explored further.
In recent times, there has also been a shift towards patient-centric care, where the focus is not only on treating conditions but also on improving the overall patient experience during treatment. The US healthcare system emphasizes shared decision-making and patient education regarding procedures, which influences the demand for ureteral stents favorably. Moreover, regulatory bodies such as the FDA play a crucial role in ensuring the safety and efficacy of medical devices, further shaping market trends as they approve new and innovative stent solutions.
Overall, the US Ureteral Stents Market is evolving in response to healthcare trends that prioritize technological advancement, increased procedural volume, and improved patient care pathways.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In the United States, the increasing prevalence of urological diseases such as kidney stones and bladder issues is a significant driver for the US Ureteral Stents Market Industry. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 1 in 10 Americans will experience a kidney stone in their lifetime, with more than 500,000 hospital visits yearly due to kidney stones. The demand for ureteral stents is heightened by the need for effective management and treatment options for these conditions.
Additionally, the aging population in the US, which is projected to reach 95 million by 2060 according to the Census Bureau, is expected to increase the demand for ureteral stenting procedures as older individuals are more prone to urological issues. Established organizations like the American Urological Association are crucial players in providing education and guidelines that impact the market landscape, emphasizing the need for more advanced treatment devices, including ureteral stents.
Innovations in ureteral stent design, such as the development of biocompatible materials and advanced delivery systems, are driving the US Ureteral Stents Market Industry. Recent developments include the introduction of coated and biodegradable stents that enhance patient comfort and reduce complications. According to the Food and Drug Administration, more than 20 new ureteral stent products have been approved for use in the past five years, significantly impacting the treatment landscape.
Medical device manufacturers like Boston Scientific and Cook Medical are investing heavily in Research and Development to enhance stent technology, thus catering to the growing demand for improved stent solutions and expanding market potential.
There is a rising trend of health awareness and preventive screening programs in the US that are contributing to the growth of the US Ureteral Stents Market Industry. More healthcare professionals advocate for early detection and management of urological issues, leading to an increase in screenings for conditions such as kidney stones. The Centers for Disease Control and Prevention reports that health screening initiatives have improved the diagnosis rates of critical ailments.
This growing focus on preventive care has led to an increased demand for ureteral stents, as more patients become aware of their urological health and seek treatment options. Furthermore, the involvement of health organizations and industry bodies, like the Urology Care Foundation, in promoting awareness campaigns enhances the visibility and perceived need for advanced medical solutions in urology.
The US Ureteral Stents Market is structured into various types, serving diverse clinical needs and applications, with notable segments including Double Pigtail Ureteral Stent and others. The Double Pigtail Ureteral Stent, recognized for its unique design featuring coiled ends that help secure the stent in place, plays a crucial role in managing urinary obstructions and ensuring proper urinary drainage. This type of stent has gained popularity due to its effectiveness in various procedures, such as ureteroscopy, as well as its lower risk of complications compared to traditional stents.
On the other hand, the segment categorized as 'Others' encompasses a range of alternative stent designs and materials, which cater to specific patient requirements or unique medical conditions. This diversity allows for tailoring patient management strategies, enhancing treatment effectiveness while also minimizing discomfort. The demand for both segments is primarily driven by the increasing prevalence of urological conditions in the United States, leading to higher revascularization rates and a push for innovative solutions in urinary tract management.
The awareness of stent-related complications further fuels growth in the market, as healthcare professionals increasingly opt for designs that mitigate risks associated with prolonged use. Factors such as technological advancements in stent materials and designs, alongside the growing geriatric population susceptible to urological disorders, offer numerous growth opportunities for the US Ureteral Stents Market. Specifically, advancements in biocompatible materials have shown the potential to enhance patient comfort and stent lifespan, fostering a favorable outlook for type-specific innovations.
The overall market growth and segmentation dynamics are reflective of ongoing trends, which emphasize patient-centric solutions, safety, and efficacy. Continued Research and Development efforts in both Double Pigtail Ureteral Stent and other designs highlight the commitment to improving clinical outcomes and patient quality of life in the US healthcare landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Ureteral Stents Market is significantly influenced by the material segment, which includes categories such as Metallic Stents, Polymers Stents, and others. In recent years, the emphasis on biocompatible materials has gained traction, as it enhances patient comfort and minimizes the risk of complications. Metallic Stents are known for their strength, durability, and ability to provide consistent drainage, making them a preferred choice for long-term usage in patients with obstructions.
On the other hand, Polymers Stents have emerged as an important option due to their flexibility and ease of implantation, catering to varied patient needs. The versatility of both material types supports their usage in different clinical scenarios, contributing to the overall growth of the US Ureteral Stents Market. The dynamics of innovation and Research and Development in these materials further drive advancements, allowing for enhanced stent designs that can improve patient outcomes. As the healthcare landscape evolves, these segments are pivotal in addressing the complexities of urinary tract obstructions while ensuring patient safety and satisfaction, reflecting ongoing trends and demands in the medical device industry.
The Treatment segment of the US Ureteral Stents Market is pivotal in addressing various urinary tract conditions. This segment primarily focuses on three key areas: Kidney Stones, Kidney Transplant, and other related conditions. Kidney Stones treatment has been prominent due to the high prevalence of renal calculi in the US population, with millions affected annually, thereby necessitating effective solutions. Kidney Transplant procedures also rely heavily on ureteral stenting to ensure proper urine flow post-surgery, significantly impacting patient recovery.
Additionally, other conditions such as ureteral strictures and tumors represent growing areas of concern, where stents play a critical role in management. The increasing awareness and advancements in minimally invasive urological procedures are contributing factors to the market growth, as healthcare providers seek to optimize patient outcomes while reducing recovery times. Collectively, these elements underscore the significance of the Treatment segment in enhancing healthcare delivery associated with the US Ureteral Stents Market.
The US Ureteral Stents Market encompasses a diverse range of End User settings, reflecting the multifaceted application of ureteral stents in the healthcare landscape. Hospitals represent a crucial segment, often being the primary locations for advanced urological procedures, where the demand for ureteral stents is significant due to the higher surgical volumes and complex case management typically encountered. Nephrological Centers also play a vital role, as they specialize in kidney-related disorders and require specialized ureteral stents for patient care and management of urinary obstructions.
Ambulatory Surgical Centers are becoming increasingly important as well, driven by the trend towards outpatient procedures, which encourages efficient stent placements and faster patient recovery times. Overall, the End User segment reflects the evolving dynamics of healthcare delivery in the US, driven by the need for improved patient outcomes, advancements in medical technology, and the growing prevalence of urinary conditions that necessitate the use of ureteral stents in various healthcare settings.
The US Ureteral Stents Market is characterized by intense competition, driven by the continuous advancements in medical technology and an increasing prevalence of kidney-related disorders. The market includes a variety of stakeholders such as manufacturers, healthcare professionals, and patients, all of whom play significant roles in the growth and development of ureteral stents. As a pivotal area within the broader urology market, ureteral stents serve crucial functions in managing various conditions, including urinary obstructions, and the choice of stents can greatly impact patient outcomes. Companies within this sector continually strive to innovate and enhance the performance of their products, often working in collaboration with healthcare providers to optimize surgical procedures and improve patient care. The competitive landscape is further influenced by regulatory challenges, evolving reimbursement policies, and increasing awareness regarding the importance of effective ureteral stenting.
Teleflex stands out in the US Ureteral Stents Market due to its robust commitment to innovation and quality. The company has established a strong market presence by offering a diverse range of ureteral stenting solutions that emphasize safety, efficiency, and reliability. Teleflex focuses on enhancing its product portfolio through ongoing research and development efforts, ensuring that its stents meet the evolving needs of healthcare professionals and patients alike. The company's emphasis on strong customer relationships and its reputation for high-quality products position it advantageously within the market. Additionally, proactive marketing strategies and an extensive distribution network allow Teleflex to effectively reach key healthcare providers, ensuring that its products are widely accessible in various clinical settings across the United States.
Auris Health is another key player in the US Ureteral Stents Market, known for its innovative approaches to minimally invasive surgical techniques. The company's strong focus on advanced technologies has positioned it favorably, allowing it to provide state-of-the-art ureteral stenting solutions. Auris Health's products emphasize precision and ease of use, which are crucial in urological procedures. The company's growth is further bolstered by strategic mergers and acquisitions, which have expanded its market presence and enhanced its offerings. With a commitment to improving patient outcomes and clinician efficiency, Auris Health continues to push the boundaries of technology in urology. Its extensive product line, combined with an agile approach to meeting market demands, enables Auris Health to maintain a competitive edge in the US ureteral stents arena.
Recent developments in the US Ureteral Stents Market have witnessed ongoing innovations and strategic activities by leading companies. Teleflex recently announced advancements in its urology product line, emphasizing improved patient outcomes and enhanced usability. Notably, in September 2023, Boston Scientific launched a new ureteral stent that is designed for easier placement, responding to the growing demand for minimally invasive options. Medtronic has focused on expanding its presence through a series of collaborations and R&D efforts targeting better stent materials for improved biocompatibility.
As for mergers and acquisitions, C.R. Bard, now a part of BD, has been strategically consolidating its product offerings, with BD's acquisition completed in December 2017 still influencing market dynamics. Moreover, UroGen Pharma has been gaining attention for its innovative drug-device combinations in urinary tract treatments, enhancing its market valuation. In the last couple of years, significant growth has been noted in the Ureteral Stents Market, with increasing adoption rates attributed to rising incidences of urological disorders and advancements in healthcare technologies. The landscape remains competitive, with companies like Smiths Medical and CooperSurgical continuously evolving their product strategies to align with growing patient needs.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 122.82(USD Million) |
| MARKET SIZE 2024 | 130.0(USD Million) |
| MARKET SIZE 2035 | 240.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.732% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Teleflex, Auris Health, C.R. Bard, Smiths Medical, B. Braun, Boston Scientific, Coloplast, Medtronic, MediFlex, UroGen Pharma, Stryker, Richard Wolf, Cook Medical, Johnson and Johnson, CooperSurgical |
| SEGMENTS COVERED | Type, Material, Treatment, End User |
| KEY MARKET OPPORTUNITIES | Rising prevalence of kidney disorders, Technological advancements in stent design, Increasing aging population, Growing adoption of minimally invasive procedures, Expanding outpatient surgical centers |
| KEY MARKET DYNAMICS | Increasing prevalence of urinary disorders, Technological advancements in stent design, Rising geriatric population, Growing awareness and education, Expanding healthcare infrastructure |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Ureteral Stents Market is expected to be valued at 130.0 million USD in 2024.
By 2035, the market is projected to reach 240.0 million USD.
The expected CAGR for the US Ureteral Stents Market from 2025 to 2035 is 5.732%.
The major types of ureteral stents include Double Pigtail Ureteral Stent and other types.
The market for Double Pigtail Ureteral Stents is valued at 75.0 million USD in 2024.
The anticipated market size for other types of ureteral stents is projected to be 100.0 million USD by 2035.
Key players in the market include Teleflex, Auris Health, C.R. Bard, and Boston Scientific among others.
Emerging trends and the increasing prevalence of urological conditions present significant growth opportunities.
The competitive landscape is diverse, with major companies vying for market share in a growing sector.
Challenges include regulatory hurdles and the need for innovation in stent technology.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
